Company Filing History:
2 out of 1,507 
1 out of 34 
1 out of 2,355 
Years Active: 2020-2025
Title: The Innovative Contributions of Andrew Huntsman
Introduction
Andrew Huntsman is a notable inventor based in Fort Jennings, Ohio. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, Huntsman has focused on developing compounds that exhibit anti-cancer properties.
Latest Patents
Huntsman's latest patents include "Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids." This patent discloses compounds, compositions, and methods for inhibiting a histone methyltransferase. The compounds are verticillin derivatives that demonstrate anti-proliferative activity against cancer cells. Additionally, he has developed "Antitumor arylnaphthalene ligand glycosides," which describes arylnaphthalene lactone derivatives and their use as anticancer agents.
Career Highlights
Throughout his career, Andrew Huntsman has worked with reputable organizations such as the Ohio State Innovation Foundation and the University of North Carolina at Greensboro. His work has contributed to advancements in cancer treatment and research.
Collaborations
Huntsman has collaborated with notable colleagues, including James Fuchs and Alan Douglas Kinghorn. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Andrew Huntsman is a dedicated inventor whose work in cancer research has the potential to make a significant impact on treatment options. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.